Atlas Trials

Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,

Clinical trial NCT06762483 · RECRUITING

Trial details

NCT number
NCT06762483
Sponsor
European Institute of Oncology
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer, Metastatic
Start date
2024-12-20
Primary completion
2026-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.